Prescription Drug News and Research

RSS

InhibOx and COSMIC discoveries align to deliver full service drug discovery offering

InhibOx Ltd (spin-out of Oxford, UK) and the COSMIC Discoveries (the independent service arm of the Institute of Life Sciences, Hyderabad, India) today announce that they have formed a close strategic partnership to deliver a full service drug discovery service offering, incorporating expert computational, medicinal and synthetic chemistry design capabilities. Both commercial organizations, linked to world-leading academic institutes, have built their services on advanced proprietary science and technology. Together, they offer unique capabilities that are able to address the most demanding drug discovery challenges on behalf of biotech and pharmaceutical companies worldwide.

15 Mar 2011

Study evaluates potential national savings from discount generic medication programs

If all eligible patients filled their prescriptions through a $4 generic drug program, the societal savings could amount to nearly $6 billion, according to a University of Pittsburgh Graduate School of Public Health study.

15 Mar 2011

State roundup: Medicaid cuts cause unusual bedfellows

Representatives from Arizona hospitals, nursing homes and health plans are set to meet with Gov. Jan Brewer today. They hope to win her support for a plan to impose a tax on their institutions and avoid deep cuts to Arizona's Medicaid program. The plan reportedly includes a cap on funding for childless adults, a group now covered under the Arizona Health Care Cost Containment System that could lose coverage Oct. 1. (Reinhart, 3/11).

14 Mar 2011

Pilot entrepreneur creates ultra-luxe alcohol and addiction rehabilitation facility

When a lawyer or judge crashes their Porsche into a ditch, a physician is found with an IV in her arm or a pilot is caught in the cockpit with alcohol on his breath, bar cards, medical and pilot licenses are revoked and careers are ruined.

10 Mar 2011

Survey reveals impact of health care law on seniors

A survey of 460 seniors 65 and older revealed that 70% believe the Patient Protection and Affordable Care Act will reduce their Medicare benefits, despite the fact that the bill does not cut Medicare benefits and instead adds some, including a yearly free checkup and other free preventive care services.

10 Mar 2011

Stemline's SL-401 receives FDA Orphan Drug designation for treatment of acute myeloid leukemia

Stemline Therapeutics, Inc. today announced that SL-401, the Company's lead compound, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of acute myeloid leukemia (AML).

10 Mar 2011

CHSI enters definitive agreement to acquire WHI for $525 million

Catalyst Health Solutions, Inc. announced that it has entered into a definitive agreement with Walgreen Co. to acquire Walgreens' pharmacy benefit management subsidiary, Walgreens Health Initiatives, Inc., for $525 million in cash.

9 Mar 2011

The American Journal of Medicine focuses on the continuing healthcare reform debate

As the debate about healthcare in the United States rages, four insightful articles in the March 2011 issue of The American Journal of Medicine strive to add reasoned arguments and empirical research findings to the dialog.

9 Mar 2011

FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for dapagliflozin, an investigational compound for the treatment of adults with type 2 diabetes mellitus.

9 Mar 2011

Humana joins with iCan to offer new individual healthcare plans

Humana Inc. (NYSE: HUM) has teamed with the iCan Benefit Group to offer a new line of discounted products for individual consumers. Effective immediately, people can access a variety of discounted packages that include dental, vision and pharmacy products.

8 Mar 2011

FLSPMP moves to set record straight on issue of patient privacy, PDMP

The Florida Society of Pain Management Providers moves to set the record straight on the issue of patient privacy and the Prescription Drug Monitoring Program.

5 Mar 2011

Few primary care physicians pay adequate attention to patients taking prescription opioid drugs

Few primary care physicians pay adequate attention to patients taking prescription opioid drugs — despite the potential for abuse, addiction and overdose, according to a new study by researchers at Albert Einstein College of Medicine of Yeshiva University.

4 Mar 2011

Viewpoints: Medicaid costs making Ohio 'ill'?; Penn. adultbasic cuts 'bad'; Calif.'s prisoner dilemma

The president's health care overhaul has made Ohio's budget situation worse. The law prohibits states from changing eligibility requirements, cutting reimbursements or reducing benefits, which would allow our state to live within its means.

4 Mar 2011

Health care fraud a hot topic on Capitol Hill

Hearings in the House and Senate Wednesday examined public and private efforts to address health care fraud. And the Government Accountability Office issued a new report on fraudulent or improper billing to Medicare.

3 Mar 2011

Clinical trials in Australia take too long– need uniform standards: Report

A government report says that clinical trials for new medicines are taking too long and should be sped up so patients can access urgently needed treatment. The states and territories have been urged to adopt uniform rules on approving trials so the scientific experiments can be conducted more efficiently and effectively.

3 Mar 2011

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.

3 Mar 2011

New drug approved for COPD by the FDA

The U.S. FDA has approved a new treatment for people with worsening symptoms of severe chronic obstructive pulmonary disease (COPD). COPD affects smokers and the elderly and leads to severe difficulty in breathing, chronic cough and excessive mucus production. An exacerbation can last up to several weeks and result in a decline in lung function and increased risk of death, and it may be associated with severe anxiety, the FDA says.

1 Mar 2011

Viewpoints: Judge Kessler's decision; Utah is role model; Malpractice system flaws

The Republican strategy is to split the vast middle and working classes -- pitting unionized workers against nonunionized, public-sector workers against nonpublic, older workers within sight of Medicare and Social Security against younger workers who don't believe these programs will be there for them and the poor against the working middle class.

28 Feb 2011

Celgene's ISTODAX sNDA granted FDA Priority Review classification for progressive/relapsed PTCL

Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.

28 Feb 2011

Acasti receives conditional approval for listing of class A shares on TSX-Venture

Neptune Technologies & Bioressources Inc. and Acasti Pharma, a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares on the TSX Venture Exchange under the ticker symbol APO.

28 Feb 2011

Prescription Drug News and Research

InhibOx and COSMIC discoveries align to deliver full service drug discovery offering

Study evaluates potential national savings from discount generic medication programs

State roundup: Medicaid cuts cause unusual bedfellows

Pilot entrepreneur creates ultra-luxe alcohol and addiction rehabilitation facility

Survey reveals impact of health care law on seniors

Stemline's SL-401 receives FDA Orphan Drug designation for treatment of acute myeloid leukemia

CHSI enters definitive agreement to acquire WHI for $525 million

The American Journal of Medicine focuses on the continuing healthcare reform debate

FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review

Humana joins with iCan to offer new individual healthcare plans

FLSPMP moves to set record straight on issue of patient privacy, PDMP

Few primary care physicians pay adequate attention to patients taking prescription opioid drugs

Viewpoints: Medicaid costs making Ohio 'ill'?; Penn. adultbasic cuts 'bad'; Calif.'s prisoner dilemma

Health care fraud a hot topic on Capitol Hill

Clinical trials in Australia take too long– need uniform standards: Report

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

New drug approved for COPD by the FDA

Viewpoints: Judge Kessler's decision; Utah is role model; Malpractice system flaws

Celgene's ISTODAX sNDA granted FDA Priority Review classification for progressive/relapsed PTCL

Acasti receives conditional approval for listing of class A shares on TSX-Venture

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News